866-997-4948(US-Canada Toll Free)

Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Review and Analysis

Published By :

GlobalData

Published Date : Nov 2011

Category :

Surgical Equipment

No. of Pages : 38 Pages


Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 Review and Analysis

GlobalDatas report, Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 Review and Analysis provides key information, analysis on research studies and companies with their exhibited products at the TCT 2011 Conference. The report provides the highlights of the meeting, presentations, market dynamics and key participants with description on their exhibited products. 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Key players and their exhibited products. 
  • Qualitative analysis on key research presentations and its impact on the market. 
Reasons to buy

  • Develop business strategies by understanding the activities and developments at TCT 2011 Conference that can have an impact on the market.
  • Design and develop your product development, marketing and sales strategies 
  • Exploit M&A opportunities by identifying key market players and their products
  • Develop market-entry and market expansion strategies
  • Identify key players best positioned to take advantage of the market opportunities
Table of Contents

1 Table of Contents 3

2 Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Highlights 6
2.1 PARTNER Cohort B Two-Year Results Support Use of TAVR for Patients with Severe Aortic Stenosis who are Inoperable 6
2.2 PARTNER Cohort A QOL - Clinical Evidence shows Improved QOL with TAVR with Transfemoral Approach 6
2.3 PARTNER Cohort A CE: Cost-Effectiveness Analysis from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement versus Surgical Aortic Valve Replacement in High-Surgical-Risk Patients with Aortic Stenosis 7
2.4 New Data Reinforces Clinical Performance of Abbott's ABSORB Bioresorbable Vascular Scaffold 7
2.5 Boston Scientifics SYNERGY Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element Platinum Chromium Stent 8
2.6 Boston Scientific's PROMUS Element Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients with Long Coronary Lesions 9
2.7 Boston Scientific's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program 10
2.8 Boston Scientific's Carotid WALLSTENT Monorail Endoprosthesis Found Safe in Study of High Surgical Risk Patients in Routine Clinical Practice 11
2.9 Medtronics Resolute Drug-Eluting Stent Shows Strong Results, even in Challenging Diabetes Patients with Coronary Disease 12
2.10 Medtronic's Endeavor Drug-Eluting Stent Demonstrates Long-Term Advantages over Taxus DES 13
2.11 BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon 13
2.12 MAQUET Cardiovascular Announces FDA 510(k) Clearance and CE Mark for CARDIOSAVE Intra-Aortic Balloon Pump 14
2.13 CryoPlasty Therapy with Boston Scientifics PolarCath Dilatation System Reduces Restenosis Rates by Nearly 50% in Peripheral Stenting Procedures 15
2.14 Tryton Announces Successful Live Case Transmission on Tryton Side Branch Stent 16
2.15 St. Judes Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study 17
2.16 New Data Confirms Early Implantation of Abiomeds Impella 2.5 prior to PCI Improves Survival in Shock Patients 17
2.17 BioFreedom FIM Trial Demonstrates Comparable Long-Term Safety and Efficacy to Conventional Drug-Eluting Stent 18
2.18 Genous Stent Demonstrates most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation 19
2.19 Carotid Artery Stenting Possible for High Risk Patients with Lesions 19
2.20 ADP Antagonists found to be Significant Predictors of Stent Thrombosis within 30 Days 20
2.21 Risk of Late Thrombosis for First Generation DES found to Continue for up to Seven Years 20
2.22 Coronary Thrombectomy in Conjunction with Percutaneous Coronary Intervention Can Improve the Rates of ST-Segment Elevation Resolution 21
2.23 Non-Adherence to Anti-Platelet Regimens in Stented Patients Leads to Higher Rates of both Ischemic and Bleeding Events at 30 Days 21
2.24 TAVI found Unsafe Compared to SAVR in Elderly Patients in Preliminary Results 22
2.25 Transradial Approach Found to be Effective for Patients with ST Elevation Acute Coronary Syndrome 22
2.26 Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System 23

3 Key Companies and their Products 24
3.1 Abbott Laboratories 24
3.1.1 Absorb 24
3.1.2 MitraClip System 24
3.1.3 XIENCE PRIME Everolimus Eluting Coronary Stent System 24
3.2 Abiomed, Inc 24
3.2.1 Impella LP 2.5 - PCI 24
3.3 Biosensors International Group, Ltd 25
3.3.1 AXXESS Biolimus A9 Eluting Bifurcation Stent System 25
3.3.2 BioFreedom 25
3.3.3 BioMatrix Flex Drug Eluting Stent 25
3.4 BIOTRONIK SE & Co. KG 25
3.4.1 PRO-Kinetic Energy Stent System 25
3.4.2 Pantera LUX Paclitaxel Releasing Balloon 26
3.5 Boston Scientific 26
3.5.1 SYNERGY Coronary Stent 26
3.6 Cappella Inc. 26
3.6.1 Sideguard 26
3.7 Cardiac Dimensions 27
3.7.1 CARILLON Mitral Contour System 27
3.8 Cardiovascular Systems, Inc 27
3.8.1 Diamondback 360 - Calcified Coronary Lesions 27
3.9 Corindus, Inc. 27
3.9.1 CorPath 200 Robotic PCI System 27
3.10 Edwards Lifesciences Corporation 28
3.10.1 Edwards SAPIEN Transcatheter Heart Valve - RetroFlex 3 Delivery System 28
3.11 Flexible Stenting Solutions, Inc 28
3.11.1 Carotid Stent 28
3.11.2 FlexStent Femoropopliteal Self Expanding Stent System 28
3.11.3 Tibial SE FlexStent 28
3.12 InfraReDx, Inc. 29
3.12.1 TVC Imaging System 29
3.13 InSeal Medical Ltd. 29
3.13.1 InSeal Intravascular Closure Device 29
3.14 InspireMD Ltd. 29
3.14.1 MGuard 29
3.15 Lake Region Medical 30
3.15.1 Anchorwire Guidewires 30
3.15.2 TRAILRUNNER Guidewires 30
3.16 MAQUET 30
3.16.1 Cardiosave Intra-Aortic Balloon Pump (IABP) 30
3.17 MEDRAD, Inc 31
3.17.1 Next Generation Cotavance 31
3.18 Medtronic 31
3.18.1 23 Millimeter CoreValve on a 16 French Delivery System 31
3.18.2 26 Millimeter CoreValve System 31
3.18.3 29 Millimeter CoreValve System 31
3.18.4 31 Millimeter CoreValve System 31
3.18.5 Endeavor Resolute 31
3.18.6 Assurant Cobalt Iliac Balloon-Expandable Stent System 32
3.18.7 Complete SE (Self-Expandable) Vascular Stent System 32
3.18.8 IN.PACT Admiral Drug Eluting Balloon 32
3.18.9 IN.PACT Amphirion Paclitaxel Eluting Balloon Catheter 32
3.18.10 IN.PACT Falcon PTCA Balloon Catheter 32
3.18.11 IN.PACT Pacific Balloon Catheter 33
3.18.12 Endurant AAA Stent Graft System 33
3.18.13 Symplicity Catheter System 33
3.19 Micell Technologies, Inc. 33
3.19.1 MiStent DES 33
3.20 OrbusNeich 34
3.20.1 Combo Bio-Engineered Sirolimus Eluting Stent 34
3.20.2 Genous Bio-Engineered R Stent 34
3.21 REVA Medical, Inc. 34
3.21.1 ReZolve Bioresorbable Coronary Stent 34
3.22 Sunshine Heart Company, Pty. Ltd. 35
3.22.1 C-Pulse Heart Assist System 35
3.23 Svelte Medical Systems 35
3.23.1 Acrobat Stent-on-a-Wire Sirolimus Drug Eluting Stent 35
3.24 Tryton Medical, Inc 36
3.24.1 TRYTON Side Branch Stent System 36
3.25 Volcano Corporation 36
3.25.1 Eagle Eye Gold IVUS Imaging Catheter 36
3.25.2 Eagle Eye Platinum Digital IVUS Catheter 36
3.25.3 PrimeWire PRESTIGE Plus Pressure Guide Wire Device 37
3.25.4 Volcano s5/s5i Intravascular Ultrasound Imaging System 37
3.25.5 FL.IVUS Imaging System 37
3.25.6 Forward Looking ICE 37
3.25.7 Impact Micro-Catheter 37
3.25.8 LVOCT System 37
3.25.9 NC VIBE Imaging Balloon Catheter 37
3.25.10 Next Generation Phased Array IVUS Catheter 38
3.25.11 Next Generation Revolution Catheter 38
3.25.12 Preview Forward Looking IVUS Catheter & System 38
3.25.13 VALET Micro-Catheter 38
3.25.14 VIBE RX Vascular Imaging Balloon Catheter 38
3.25.15 Volcano OCT System 38
3.25.16 Volcano-Xtract Thrombectomy Catheter 38
3.26 Disclaimer 38

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *